KARLA MCCANN: Open Payments
NPI 1730162538 · FORD CITY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 28 payments from 12 companies in 2025. Trend: 2023 $220 · 2024 $411 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $159 |
| Novo Nordisk Inc | 6 | $108 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, VOQUEZNA, MOUNJARO, PREVNAR 20, Dexcom G6 Transmitter, JARDIANCE, Wegovy, XIFAXAN.
Industry payments across PA — which companies pay providers there.
